Prot #TOS‐358‐001: A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide‐3‐Kinase (PI3K)‐alpha Inhibitor, TOS‐358, in Adult Subjects with Select Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date11/1/23 → 11/1/26

Funding

  • PPD Development (Prot #TOS-358-001 // Prot #TOS-358-001)
  • Totus Medicines, Inc. (Prot #TOS-358-001 // Prot #TOS-358-001)